These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Pseudomonas aeruginosa exploits lipid A and muropeptides modification as a strategy to lower innate immunity during cystic fibrosis lung infection. Cigana C; Curcurù L; Leone MR; Ieranò T; Lorè NI; Bianconi I; Silipo A; Cozzolino F; Lanzetta R; Molinaro A; Bernardini ML; Bragonzi A PLoS One; 2009 Dec; 4(12):e8439. PubMed ID: 20037649 [TBL] [Abstract][Full Text] [Related]
6. Harnessing Neutrophil Survival Mechanisms during Chronic Infection by Marteyn BS; Burgel PR; Meijer L; Witko-Sarsat V Front Cell Infect Microbiol; 2017; 7():243. PubMed ID: 28713772 [TBL] [Abstract][Full Text] [Related]
7. Innate lung defenses and compromised Pseudomonas aeruginosa clearance in the malnourished mouse model of respiratory infections in cystic fibrosis. Yu H; Nasr SZ; Deretic V Infect Immun; 2000 Apr; 68(4):2142-7. PubMed ID: 10722612 [TBL] [Abstract][Full Text] [Related]
8. Cystic Fibrosis Transmembrane Conductance Regulator Attaches Tumor Suppressor PTEN to the Membrane and Promotes Anti Pseudomonas aeruginosa Immunity. Riquelme SA; Hopkins BD; Wolfe AL; DiMango E; Kitur K; Parsons R; Prince A Immunity; 2017 Dec; 47(6):1169-1181.e7. PubMed ID: 29246444 [TBL] [Abstract][Full Text] [Related]
9. Bioelectric characterization of epithelia from neonatal CFTR knockout ferrets. Fisher JT; Tyler SR; Zhang Y; Lee BJ; Liu X; Sun X; Sui H; Liang B; Luo M; Xie W; Yi Y; Zhou W; Song Y; Keiser N; Wang K; de Jonge HR; Engelhardt JF Am J Respir Cell Mol Biol; 2013 Nov; 49(5):837-44. PubMed ID: 23782101 [TBL] [Abstract][Full Text] [Related]
10. Phagocytic and signaling innate immune receptors: are they dysregulated in cystic fibrosis in the fight against Pseudomonas aeruginosa? Sallenave JM Int J Biochem Cell Biol; 2014 Jul; 52():103-7. PubMed ID: 24508137 [TBL] [Abstract][Full Text] [Related]
11. Resistance to Pseudomonas aeruginosa chronic lung infection requires cystic fibrosis transmembrane conductance regulator-modulated interleukin-1 (IL-1) release and signaling through the IL-1 receptor. Reiniger N; Lee MM; Coleman FT; Ray C; Golan DE; Pier GB Infect Immun; 2007 Apr; 75(4):1598-608. PubMed ID: 17283089 [TBL] [Abstract][Full Text] [Related]
12. Effect of polarized release of CXC-chemokines from wild-type and cystic fibrosis murine airway epithelial cells. Farberman MM; Ibricevic A; Joseph TD; Akers KT; Garcia-Medina R; Crosby S; Clarke LL; Brody SL; Ferkol TW Am J Respir Cell Mol Biol; 2011 Aug; 45(2):221-8. PubMed ID: 20639462 [TBL] [Abstract][Full Text] [Related]
13. Evidence of early increased sialylation of airway mucins and defective mucociliary clearance in CFTR-deficient piglets. Caballero I; Ringot-Destrez B; Si-Tahar M; Barbry P; Guillon A; Lantier I; Berri M; Chevaleyre C; Fleurot I; Barc C; Ramphal R; Pons N; Paquet A; Lebrigand K; Baron C; Bähr A; Klymiuk N; Léonard R; Robbe-Masselot C J Cyst Fibros; 2021 Jan; 20(1):173-182. PubMed ID: 32978064 [TBL] [Abstract][Full Text] [Related]
14. Induction of type I interferon signaling by Pseudomonas aeruginosa is diminished in cystic fibrosis epithelial cells. Parker D; Cohen TS; Alhede M; Harfenist BS; Martin FJ; Prince A Am J Respir Cell Mol Biol; 2012 Jan; 46(1):6-13. PubMed ID: 21778412 [TBL] [Abstract][Full Text] [Related]
15. Mouse models of chronic lung infection with Pseudomonas aeruginosa: models for the study of cystic fibrosis. Stotland PK; Radzioch D; Stevenson MM Pediatr Pulmonol; 2000 Nov; 30(5):413-24. PubMed ID: 11064433 [TBL] [Abstract][Full Text] [Related]
16. Airway epithelial control of Pseudomonas aeruginosa infection in cystic fibrosis. Campodónico VL; Gadjeva M; Paradis-Bleau C; Uluer A; Pier GB Trends Mol Med; 2008 Mar; 14(3):120-33. PubMed ID: 18262467 [TBL] [Abstract][Full Text] [Related]
17. Azithromycin reduces exaggerated cytokine production by M1 alveolar macrophages in cystic fibrosis. Meyer M; Huaux F; Gavilanes X; van den Brûle S; Lebecque P; Lo Re S; Lison D; Scholte B; Wallemacq P; Leal T Am J Respir Cell Mol Biol; 2009 Nov; 41(5):590-602. PubMed ID: 19244203 [TBL] [Abstract][Full Text] [Related]
18. A novel host defense system of airways is defective in cystic fibrosis. Moskwa P; Lorentzen D; Excoffon KJ; Zabner J; McCray PB; Nauseef WM; Dupuy C; Bánfi B Am J Respir Crit Care Med; 2007 Jan; 175(2):174-83. PubMed ID: 17082494 [TBL] [Abstract][Full Text] [Related]